Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Russia accidentally destroys its only way of sending astronauts to space- What happened to Eleven after the ambiguous 'Stranger Things' series finale? Millie Bobby Brown knows — but 'swore herself to secrecy'
- 5 Great and High Evaluated Scene Configuration Administrations For 2024
- Vote in favor of Your Number one Smartwatch: Exactness and Style Matter
- Surging measles cases are 'fire alarm' warning that other diseases could be next
- Top Pastry: What's Your Sweet Treat of Decision?
- Somaliland denies trading recognition with Israel for accepting Gazans
- Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
- Figure out How to Track the Establishment of New 5G Pinnacles
